Updated:
Daewon Pharmaceuticals
Daewon Pharmaceuticals was established in 1958 in South Korea. Baek Seung-ho serves as chairman and second-generation owner. His brother Baek Seung-yeol is...
Daewon Pharmaceuticals
Daewon Pharmaceuticals was established in 1958 in South Korea. Baek Seung-ho serves as chairman and second-generation owner. His brother Baek Seung-yeol is vice chairman. Baek In-hwan, son of Baek Seung-ho, holds the roles of president and CEO. The company operates as a corporate investor in biopharmaceuticals. It maintains three production and research facilities inside South Korea. Daewon holds membership in Seoul Bio Hub for startup discovery and participates in the MIT Japan Conference. Heart to Heart Foundation serves as the associated philanthropic vehicle. No recent operational events from the last 24 months appear in available records. Team size and deployment figures remain undisclosed.
General information
Firm type
Corporate Investor
Year founded
1958
AUM
Undisclosed
Location
Region
Asia
Country
South Korea
City
Seoul
Corporate office
Seoul, South Korea
Principals
Baek Seung-ho
Chairman
Baek Seung-yeol
Vice Chairman
Baek In-hwan
President and CEO
Baek In-yeong
CEO of SD Biotechnologies
Sector focus
Frequently asked questions
Who runs investment decisions at Daewon Pharmaceuticals?
Baek In-hwan serves as president and CEO. Baek Seung-ho chairs the firm as second-generation owner.
Where does the underlying wealth come from?
The firm originated as a biopharmaceuticals company established in 1958.
Does Daewon Pharmaceuticals maintain philanthropic structures?
Heart to Heart Foundation operates as the associated philanthropic vehicle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: